OR WAIT null SECS
© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
September 14, 2021
Decades of efforts to find effective medical treatments for dementia and Alzheimers disease have largely failed. Would a public health approach be more effective?
August 10, 2021
What advice can clinicians give patients to lower their overall risk for neurodegenerative diseases?
July 14, 2021
Apathy occurs throughout the spectrum of neurocognitive disorders, but it is easy to mistake for other conditions, like depression. How can clinicians identify apathy, and treat it?
May 30, 2021
Sleep problems are understudied, underdiagnosed, and undertreated.
May 29, 2021
Gene expressions in microglia cells may explain why some of them are ineffective and allow dementia to progress.
April 07, 2021
CRL cites lack of substantial evidence of efficacy needed for approval.
March 17, 2021
Aducanumab is named 1 of the 5 “Drugs to Watch” for 2021.
March 15, 2021
About 2.4 million people in the US experience dementia related psychosis, yet only half ever receive a diagnosis.
March 08, 2021
Handling aggression in patients with dementia can be difficult...
March 01, 2021
What dementia treatment makes an interesting appearance in classical literature?